Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo

Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo

Rongrong Li,1,2 Xuhang Shen,3 Zhengyuan Li,4 Jilong Shen,2 Hao Tang,5 Huaming Xu,6 Jilu Shen,1,7 Yuanhong Xu1 1Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China; 2Provincial Laboratories of Pathogen Biology and Zoonoses, A...

Full description

Bibliographic Details
Main Authors:	Li R, Shen X, Li Z, Shen J, Tang H, Xu H, Xu Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-11-01
Series:	Infection and Drug Resistance
Subjects:	as101 mefloquine carbapenem resistance pseudomonas aeruginosa synergy biofilm
Online Access:	https://www.dovepress.com/combination-of-as101-and-mefloquine-inhibits-carbapenem-resistant-pseu-peer-reviewed-fulltext-article-IDR

Similar Items

Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo
by: Xiaodong Zhang, et al.
Published: (2021-11-01)

An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/Avibactam, And Tobramycin Against Carbapenem-Resistant Pseudomonas Aeruginosa
by: Bekir Özer, et al.
Published: (2024-12-01)

Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant Pseudomonas aeruginosa
by: Yun-Qi Song, et al.
Published: (2023-10-01)

Carbapenem-resistant Pseudomonas aeruginosa outbreak in an intensive care unit of a teaching hospital
by: Ana C. Gales, et al.

Characterization of Antimicrobial Resistance Mechanisms and Virulence Determinants in Colistin- and Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>
by: Ellappan Kalaiarasan, et al.
Published: (2024-09-01)

Resistencia a carbapenemes en Pseudomonas aeruginosa en un periodo de 10 años en el Hospital Rawson
by: Luisa A. Orecchini, et al.
Published: (2010-12-01)

Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin In Vitro and In Vivo
by: Lingbo Wang, et al.
Published: (2023-02-01)

Killing Dynamics of Carbapenems against Pseudomonas aeruginosa Harboring Varied Determinants of Carbapenem Resistance
by: Viga Rolly, et al.
Published: (2020-06-01)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
by: Li S, et al.
Published: (2018-08-01)

Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains-Distribution of the Essential Enzymatic Virulence Factors Genes
by: Tomasz Bogiel, et al.
Published: (2020-12-01)

Plumbagin resurrect colistin susceptible against colistin-resistant Pseudomonas aeruginosa in vitro and in vivo
by: Yue Wang, et al.
Published: (2022-09-01)

Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa
by: Li-Hsin Tsao, et al.
Published: (2018-06-01)

Risk Factors and Outcomes of Patients with Carbapenem-Resistant Pseudomonas aeruginosa Bloodstream Infection
by: Wei X, et al.
Published: (2023-01-01)

Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt
by: El-Mahdy R, et al.
Published: (2019-11-01)

Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
by: Chia-Hsin Lee, et al.
Published: (2017-10-01)

Synergy between Indoloquinolines and Ciprofloxacin: An Antibiofilm Strategy against <i>Pseudomonas aeruginosa</i>
by: Emilie Charpentier, et al.
Published: (2021-10-01)

Antibiotic Sensitivity Pattern of Carbapenem-Resistant Pseudomonas Aeruginosa
by: Fatima Ali, et al.
Published: (2023-02-01)

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Namareq F. Aldardeer, et al.
Published: (2024-12-01)

Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
by: Amanda Vivo, et al.
Published: (2022-05-01)

Spread of Carbapenem Resistance by Transposition and Conjugation Among Pseudomonas aeruginosa
by: Anneke van der Zee, et al.
Published: (2018-09-01)

Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal
by: Toshihiro Takahashi, et al.
Published: (2021-09-01)

Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China
by: Yan-Yan Hu, et al.
Published: (2019-10-01)

Carbapenem Resistant Pseudomonas aeruginosa Infections in Elderly Patients: Antimicrobial Resistance Profiles, Risk Factors and Impact on Clinical Outcomes
by: Qin J, et al.
Published: (2022-04-01)

Successful Treatment of an AML Patient Infected with Hypervirulent ST463 Pseudomonas Aeruginosa Harboring Rare Carbapenem-Resistant Genes blaAFM-1 and blaKPC-2 Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Shen Y, et al.
Published: (2024-04-01)

Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
by: Skalweit MJ, et al.
Published: (2016-09-01)

Rates of gastrointestinal tract colonization of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa in hospitals in Saudi Arabia
by: B. Abdalhamid, et al.
Published: (2016-03-01)

Assessment of the Correlation Between Biofilm Formation and Resistance to Various Classes of Beta-Lactam Antibiotics
by: Somaye Karamolahi, et al.
Published: (2023-12-01)

Distinctive Regulation of Carbapenem Susceptibility in Pseudomonas aeruginosa by Hfq
by: Elisabeth Sonnleitner, et al.
Published: (2020-05-01)

Investigation of the prevalence of genes conferring resistance to carbapenems in Pseudomonas aeruginosa isolates from burn patients
by: Khosravi AD, et al.
Published: (2019-05-01)

In vitro study of effects of antibiotics on Pseudomonas aeruginosa biofilm formation
by: Jeevajothi Nathan, Priadarssini
Published: (2017)

Antibiotic Profile of Pseudomonas aeruginosa in a Tertiary Hospital in Chennai, India
by: D. Bindu, et al.
Published: (2022-03-01)

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
by: Yiwei Zhu, et al.
Published: (2021-12-01)

Ceftazidime/Avibactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Infection in Lung Transplant Recipients
by: Chen J, et al.
Published: (2023-04-01)

Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancies
by: Yuan F, et al.
Published: (2023-07-01)

Intrahospital spread of carbapenem-resistant Pseudomonas aeruginosa in a University Hospital in Florianópolis, Santa Catarina, Brazil Disseminação Intrahospitalar de Pseudomonas aeruginosa em Hospital Universitário de Florianópolis, Santa Catarina, Brasil
by: Mara Cristina Scheffer, et al.
Published: (2010-08-01)

Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant Pseudomonas aeruginosa in patients with nosocomial pneumonia
by: Yao Liu, et al.
Published: (2023-05-01)

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study
by: Gaurav Verma, et al.
Published: (2023-12-01)

A PRELIMINARY STUDY OF STEREOSELECTIVITY OF MEFLOQUINE ENANTIOMERS IN RAT
by: E. Souri., et al.
Published: (1998-12-01)

A PRELIMINARY STUDY OF STEREOSELECTIVITY OF MEFLOQUINE ENANTIOMERS IN RAT
by: E. Souri., et al.
Published: (1998-08-01)

Survey of various carbapenem-resistant mechanisms of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical samples in Iran
by: Leila Azimi, et al.
Published: (2020-11-01)